Drug & medication recalls Moderate risk

Sentara Infusion Services recalls Vancomycin (a) 1.25GM IN NS 250ML, (b) 1.5GM IN NS 300ML, (c) 1000MG IN NS 200ML (d) 2GM IN 400ML NS, (e) 900MG IN NS 1…

Recall date
December 27, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0322-2023
FDA classification
Class II
Brand / firm
Sentara Infusion Services
Sold / distributed
Dispensed to Patients Nationwide.

Why it was recalled

Lack of sterility assurance

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Vancomycin (a) 1.25GM IN NS 250ML, (b) 1.5GM IN NS 300ML, (c) 1000MG IN NS 200ML (d) 2GM IN 400ML NS, (e) 900MG IN NS 180ML, (f) 500 MG NS 100ML, (g) 750 MG NS 150ML, antibiotic, Rx only, use with home pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320

Get recall alerts

Free email alert whenever Sentara Infusion Services has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Sentara Infusion Services